Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide
Clinical trial NCT02502864 · COMPLETED
Trial details
- NCT number
- NCT02502864
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-09
- Primary completion
- 2017-09-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.